Targeted therapy and immunotherapy for orbital and periorbital tumors: a major review

Emmanuel Lee Boniao1,2, Richard C Allen3, Gangadhara Sundar1

  • 1Orbit & Oculofacial Surgery, Ophthalmic Oncology, Department of Ophthalmology, National University Hospital, National University of Singapore, Singapore, Singapore.

PubMed

Insights

Precision medicine, including targeted therapy and immunotherapy, offers new hope for managing orbital tumors. These advanced treatments provide alternatives to traditional chemotherapy, reducing toxic side effects for patients unsuitable for surgery.

Area of Science:

  • Oncology
  • Ophthalmology
  • Dermatology

Background:

  • Traditional palliative chemotherapy for orbital tumors has significant toxic side effects.
  • Advancements in tumor biology and molecular genetics enable precision medicine approaches.
  • Targeted therapy and immunotherapy represent a new era in cancer treatment.

Purpose of the Study:

  • To review recent updates on targeted and immunotherapy for orbital and periorbital tumors.
  • To highlight the application of novel therapies in managing various orbital conditions.
  • To provide an overview of current treatment strategies beyond conventional methods.

Main Methods:

  • Literature review of recent advancements in targeted therapy and immunotherapy.
  • Analysis of clinical applications for specific orbital and periorbital tumors.
  • Synthesis of data on efficacy and side effect profiles of new treatments.

Main Results:

  • Targeted therapy and immunotherapy show promise for various orbital tumors, including basal cell carcinoma, melanoma, and adenoid cystic carcinoma.
  • These precision medicine approaches offer improved outcomes with potentially fewer side effects compared to traditional chemotherapy.
  • The article discusses applications for conditions like orbital meningioma, neurofibromatosis, and ocular adnexal lymphoma.

Conclusions:

  • Targeted therapy and immunotherapy are becoming integral to managing orbital and periorbital tumors.
  • These novel treatments offer personalized options for patients, especially those with poor surgical candidacy.
  • Continued research is essential to further refine and expand the use of these advanced therapies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K